Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease
2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and …

In its wake, the COVID‐19 pandemic has ushered in a surge in the number of cases of
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …

Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …

Objectives To describe the epidemiology, management and outcome of individuals with
mucormycosis; and to evaluate the risk factors associated with mortality. Methods We …

Mucormycosis is an invasive fungal infection, often acute and extremely severe, occurring in
patients with an underlying condition. Coinfection in patients with coronavirus disease 2019 …

Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal
infections. Most documented cases have been reported in patients with diabetes mellitus …

Despite the medical advances and interventions to improve the quality of life of those in
intensive care, people with cancer or severely immunocompromised or other susceptible …

Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Background Mucormycosis, a rare fungal infection, has shown an increase in the number of
reported cases during the COVID-19 pandemic. Objectives To provide a comprehensive …

Abstract Aims Diabetes Mellitus predisposes patients to invasive fungal infections. There
has been a recent surge of Mucormycosis with COVID 19 infection particularly in patients …